- Home
- ENOV vs IBTA Comparison
ENOV vs IBTA Comparison
Compare ENOV & IBTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENOV
- IBTA
- Stock Information
- Founded
- ENOV 1995
- IBTA 2011
- Country
- ENOV United States
- IBTA United States
- Employees
- ENOV N/A
- IBTA N/A
- Industry
- ENOV Fluid Controls
- IBTA
- Sector
- ENOV Industrials
- IBTA
- Exchange
- ENOV Nasdaq
- IBTA Nasdaq
- Market Cap
- ENOV 2.1B
- IBTA 2.2B
- IPO Year
- ENOV 2008
- IBTA 2024
- Fundamental
- Price
- ENOV $33.10
- IBTA $47.74
- Analyst Decision
- ENOV Buy
- IBTA Buy
- Analyst Count
- ENOV 4
- IBTA 10
- Target Price
- ENOV $58.50
- IBTA $72.30
- AVG Volume (30 Days)
- ENOV 986.0K
- IBTA 362.5K
- Earning Date
- ENOV 05-08-2025
- IBTA 05-14-2025
- Dividend Yield
- ENOV N/A
- IBTA N/A
- EPS Growth
- ENOV N/A
- IBTA 80.28
- EPS
- ENOV N/A
- IBTA 2.56
- Revenue
- ENOV $2,150,191,000.00
- IBTA $367,254,000.00
- Revenue This Year
- ENOV $7.13
- IBTA $5.82
- Revenue Next Year
- ENOV $6.33
- IBTA $14.95
- P/E Ratio
- ENOV N/A
- IBTA $18.36
- Revenue Growth
- ENOV 18.32
- IBTA 14.75
- 52 Week Low
- ENOV $29.32
- IBTA $31.40
- 52 Week High
- ENOV $53.84
- IBTA $108.65
- Technical
- Relative Strength Index (RSI)
- ENOV 41.77
- IBTA N/A
- Support Level
- ENOV $33.48
- IBTA N/A
- Resistance Level
- ENOV $35.62
- IBTA N/A
- Average True Range (ATR)
- ENOV 1.32
- IBTA 0.00
- MACD
- ENOV 0.20
- IBTA 0.00
- Stochastic Oscillator
- ENOV 49.20
- IBTA 0.00
About ENOV Enovis Corporation
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
About IBTA Ibotta Inc. Class A Common Stock
Ibotta Inc is a performance marketing platform. It allows CPG brands to deliver digital promotions to consumers through a single, convenient network called the Ibotta Performance Network (IPN).